This Review discusses recent studies that have identified ways to increase the antitumour response of autologous tumour-reactive cells adoptively transferred to individuals with cancer, such as the use of lymphodepleting regimens before adoptive cell transfer.
- Luca Gattinoni
- Daniel J. Powell Jr.
- Nicholas P. Restifo